Prion diseases are neurodegenerative pathologies characterized by the accumulation, in the brain, of altered forms of the prion protein (PrP), named PrP Sc . A synthetic peptide homologous to residues 106 -126 of PrP (PrP106 -126) was reported to maintain the neurodegenerative characteristics of PrP Sc . We investigated the intracellular mechanisms involved in PrP106 -126-dependent degeneration of primary cultures of cerebellar granule neurons. Prolonged exposure of such neurons to PrP106 -126 induced apoptotic cell death. The L-type voltage-sensitive calcium channel blocker nicardipine reproduced this effect, suggesting that blockade of Ca 2؉ entry through this class of calcium channels may be responsible for the granule cell degeneration. Microfluorometric analysis showed that PrP106 -126 caused a reduction in cytosolic calcium levels, elicited by depolarizing K ؉ concentrations in these neurons. Electrophysiological studies demonstrated that PrP106 -126 and nicardipine selectively reduce the L-type calcium channel current. These data demonstrate that PrP106 -126 alters the activity of L-type voltage-sensitive calcium channels in rat cerebellar granule cells and suggest that this phenomenon is related to the cell death induced by the peptide.
INTRODUCTION
Prion-related encephalopathies are a group of neurodegenerative diseases including scrapie of sheep and goat, spongiform encephalopathy of cattle, and four diseases of humans: kuru, Creutzfeldt-Jakob disease, Gerstmann-Sträussler-Scheinker disease, and fatal familial insomnia. It has been proposed that these diseases recognize, as an etiopathologic agent, the conversion of the prion protein (PrP C ) into an abnormal isoform, named PrP Sc , from scrapie (Prusiner, 1998). PrP C is a glycoprotein bound to the cell surface by a phosphoinositol glycolipid (GPI) anchor; it consists of a globular region (three ␣ helices plus one ␤ sheet) and a large flexible random coiled N terminus
